Consensus EPS · Q3 2026
$2.23
Consensus revenue · Q3 2026
$1.7B
Analysts
17
Expected report
Oct 20, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 17 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $1.7B | $1.7B | $1.7B |
| EPS | $2.18 | $2.23 | $2.37 |
| EBITDA | $525.2M | $528.3M | $531.4M |
| EBIT | $333.7M | $335.6M | $337.6M |
| Net income | $249M | $265.5M | $287.8M |
- Revenue$1.7B
- EPS$2.23
- EBITDA$528.3M
- EBIT$335.6M
- Net income$265.5M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q2 2026 | $1.7B | $1.7B | +0.2% | $2.25 | $2.20 | +2.2% |
| Q1 2026 | $1.6B | $1.6B | +2.0% | $1.86 | $1.69 | +9.8% |
- Q2 2026+0.2%+2.2%
- Q1 2026+2.0%+9.8%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Equifax (EFX) Q3 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 10 analysts.
- Low
- $182.00
- Consensus
- $212.75
- Median
- $211.00
- High
- $245.00
- Current
- $170.45
- Upside
- +24.8%
Upside calculated vs most recent trading price of $170.45.
Consensus across all covering analysts. See the ranking ›
Analyst ratings
Consensus: Buy — based on 35 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 22, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Jul 22, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jul 22, 2026 | Needham | maintain | Buy | Buy |
| Jul 22, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Jul 22, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Jul 22, 2026 | Baird | maintain | Outperform | Outperform |
| Jul 8, 2026 | UBS | maintain | Buy | Buy |
| Jul 7, 2026 | Needham | maintain | Buy | Buy |
| Jul 2, 2026 | UBS | maintain | Buy | Buy |
| Jul 2, 2026 | Mizuho | maintain | Outperform | Outperform |
- Jul 22, 2026Wells FargoOverweight
- Jul 22, 2026RBC CapitalOutperform
- Jul 22, 2026NeedhamBuy
- Jul 22, 2026Morgan StanleyOverweight
- Jul 22, 2026BarclaysEqual Weight
- Jul 22, 2026BairdOutperform
- Jul 8, 2026UBSBuy
- Jul 7, 2026NeedhamBuy
- Jul 2, 2026UBSBuy
- Jul 2, 2026MizuhoOutperform
Frequently asked questions
Equifax (EFX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks7.18% TTM
- Dividend Profile1.24% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.